Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy

Nephrology

Volumn 20, Issue 8, 2015, Pages 572-575

  Kumar, Vinod ^a   Ramachandran, Raja ^a   Kumar, Ashwani ^a   Nada, Ritambhra ^a   Suri, Deepti ^a   Gupta, Anju ^a   Kohli, Harbir Singh ^a   Gupta, Krishan Lal ^a   Jha, Vivekanand ^a,b  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

Author keywords

glomerulonephritis; membranous nephropathy; nephrotic syndrome; tacrolimus

Indexed keywords

CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PHOSPHOLIPASE A2 RECEPTOR; PREDNISOLONE; TACROLIMUS; AUTOANTIBODY; BIOLOGICAL MARKER; IMMUNOSUPPRESSIVE AGENT; PLA2R1 PROTEIN, HUMAN;

ADOLESCENT; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLOMERULUS; HUMAN; HUMAN TISSUE; IDIOPATHIC MEMBRANOUS NEPHROPATHY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEINURIA; REMISSION; AGE; BIOPSY; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GLOMERULONEPHRITIS, MEMBRANOUS; IMMUNOLOGY; NEPHROTIC SYNDROME; PATHOLOGY;

ADOLESCENT; AGE FACTORS; AUTOANTIBODIES; BIOMARKERS; BIOPSY; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY GLOMERULUS; MALE; NEPHROTIC SYNDROME; RECEPTORS, PHOSPHOLIPASE A2;

EID: 84937435415     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12478     Document Type: Article

References (12)

1. Churg J, Habib R, White RH,. Pathology of the nephrotic syndrome in children: A report for the International Study of Kidney Disease in Children. Lancet 1970; 760: 1299-1302.
2. A report for the International Study of Kidney Disease in Children. Nephrotic syndrome in children: Prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int. 1978; 13: 159-165.
3. Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N. Engl. J. Med. 2009; 361: 11-21.
4. Debiec H, Ronco P,. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N. Engl. J. Med. 2011; 364: 689-690.
5. Debiec H, Guigonis V, Mougenot B, et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N. Engl. J. Med. 2002; 346: 2053-2060.
6. Beck LH Jr,. Childhood membranous nephropathy and dietary antigens. Am. J. Kidney Dis. 2012; 59: 174-176.
7. Cossey LN, Walker PD, Larsen CP,. Phospholipase A2 receptor staining in pediatric idiopathic membranous glomerulopathy. Pediatr. Nephrol. 2013; 28: 2307-2311.
8. Ponticelli C, Altieri P, Scolari F, Passerini P, Roccatello D, Cesana B,. etal. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J. Am. Soc. Nephrol. 1998; 9: 444-450.
9. Jha V, Ganguli A, Saha TK, et al. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. J. Am. Soc. Nephrol. 2007; 18: 1899-1904.
10. Chen M, Li H, Li XY, et al. Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: A multicenter randomized controlled trial. Am. J. Med. Sci. 2010; 339: 233-238.
11. Sharma V, Ramachandran R, Kumar A, et al. Association of PLA2R and HLA-DQA1 genetic variants with serum anti PLA2R antibody and clinical OUTCOME in Indian patients with idiopathic membranous nephropathy (Abstract). J. Am. Soc. Nephrol. 2014; 25: 750A.
12. Euroimmun Medizinische Labordiagnostika AG. Anti-PLA2R ELISA (IgG). Available from URL: http://www.pla2r.com/fileadmin/pla2r/pdf/Anti-PLA2R-ELISA-IgG-EN.pdf. Accessed 24 April 2015.